The Loss of Estrogen and Progesterone Receptor Gene Expression in Human Breast Cancer (original) (raw)
References
F. Borellini and T. Oka (1989). Growth control and differentiation in mammary epithelial cells. Environ. Health Perspect80:85 99. Google Scholar
D. L. Ricketts, G. Turnbull, R. Ryall, N. S. B. Bakshi, N. S. B. Raswon, J-C. Gazet, C. Nolan, and R. C. Coombes (1991). Estrogen and progesterone receptor in the normal female breast. Cancer Res.51:1817-1822. Google Scholar
O. W. Peterson, P. E. Hoyer, and B. Van Deurs (1987). Frequency and distribution of estrogen positive cells in normal, non-lactating human breast tissue. Cancer Res.47:5748-5751. Google Scholar
C. Markopoulus, U. Berger, P. Wilson, J. Gazet, and R. C. Coombes (1988). Oestrogen receptor content of normal breast cells and breast carcinoma throughout the menstrual cycle. Brit. Med. J.296:1349-1351. Google Scholar
C. W. Daniels, G. B. Silberstein, and P. Strickland (1987). Direct action of 17-beta estradiol on mouse mammary ducts analyzed by sustain release implants and steroid autoradiography. Cancer Res.47:6052-6057. Google Scholar
G. B. Silberstein, K. Van Horn, G. Shyamala, and C.W. Daniels (1994). Essential role of endogenous estrogen in directly stimulating mammary growth demonstrated by implants containing pure anti-estrogens. Endocrinology134:84-90. Google Scholar
K. S. Korach (1994). Insights from the study of animals lacking functional estrogen receptor. Science266:1524-1527. Google Scholar
J. P. Lydon, F. J. DeMayo, C. R. Funk, S. K. Mani, A. R. Hughes, C. A. Montgomery, Jr., G. Shyamala, O. M. Conneely, and B.W. O' Malley (1995). Mice lacking progesterone receptor exhibit pleiotropic reproductive abnormalities. Genes Dev.9:2266-2278. Google Scholar
J. P. Lydon, F. J. DeMayo, O. M. Conneely, and B.W. O' Malley (1996). Reproductive phenotypes of the progesterone receptor null mutant mouse. J. Steroid Biochem. Mol. Biol.56:67-77. Google Scholar
H. Gronemeyer (1991). Transcription activation by estrogen and progesterone receptors. Ann. Rev. Genet.25:89-123. Google Scholar
L. Tora, J. White, C. Brou, D. Tasset, N. Webster, E. Scheer, and P. Chambon (1989). The human estrogen receptor has two independent nonacidic transcriptional activation functions. Cell59:477-487. Google Scholar
S. Adler, M. L. Waterman, and M. G. Rosenfeld (1988). Steroid receptor-mediated inhibition of rat prolactin gene expression does not require the receptor DNA-binding domain. Cell52:685-695. Google Scholar
M. Montano, V. Muller, A. Trobaugh, and B. S. Katzenellenbogen (1995). The carboxy-termina l F domain of the human estrogen receptor: role in the transcriptional activity of the receptor and the effectiveness of antiestrogens as estrogen antagonists. Mol. Endocrinol.9:814-825. Google Scholar
B. A. Lieberman (1997). The estrogen receptor activity: dependence on multiple protein-protein interactions. Crit. Rev. Euk. Gene Exp.7:43-59. Google Scholar
W. L. Kraus, E. M. McInerney, and B. S. Katzenellenbogen (1995). Ligand-dependent, transcriptionally productive association of the amino-and carboxyl-termi nal regions of a steroid hormone nuclear receptor. Proc. Natl. Acad. Sci. USA92:12314-12318. Google Scholar
L. D. Read, C. E. Snider, J. S. Miller, G. L. Greene, and B. S. Katzenellenbogen (1988). Ligand-modulat ed regulation of progesterone receptor messenger ribonucleic acid and protein in human breast cancer cell lines. Mol. Endocrinol.2:263-271. Google Scholar
S. B. Jakowlew, R. Breathnach, J. M. Teltsa, P. Masaikowski, and P. Chambon (1984). Sequence of pS2 mRNA induced by estrogen in the human breast cancer cell line, MCF-7. Nucleic Acids Res.12:2861-2878. Google Scholar
D. Dubik and R. P. C. Shiu (1988). Transcriptional regulation of c-myc oncogene expression by estrogen in hormone-responsive human breast cancer cells. J. Biol. Chem.263:12705-12708. Google Scholar
S. E. Bates, N. E. Davidson, E. M. Valverius, C. E. Freter, R. B. Dickson, J. P. Tam, J. E. Kudlow, M. E. Lippman, and D. S. Salomon (1988). Expression of transforming growth factor and its messenger ribonucleic acid in human breast cancer: its regulation by estrogen and its possible functional significance. Mol. Endocrinol.2:543-555. Google Scholar
A. Bailly, C. Le Page, M. Rauch, and E. Milgrom (1986). Sequence specific DNA binding of progesterone receptor to the uteroglobin gene. EMBO J.5:3235-3241. Google Scholar
V. Lamian, B. Y. Gonzalez, F. J. Michel, and R. C. M. Simmen (1993). Non-consensus progesterone response elements medi-ate the progesterone-reg ulated endometrial expression of the uteroferrin gene. J. Steroid Biochem. Mol. Biol.46:439-450. Google Scholar
J. G. Gao, J. Mazella, D. R. Powell, and L. Tseng (1994). Identification of a distal regulatory sequence of the human IGFBP-1 gene promoter and regulation by progesterone recep-tor in a human endometrial adenocarcinoma cell line. DNA Cell Biol.13:829-837. Google Scholar
W. L. McGuire (1978). Hormone receptors: their role in pre-dicting prognosis and response to endocrine therapy. Seminar Oncol.5:428-433. Google Scholar
G. L. Greene, P. Hilna, M. Waterfield, A. Baker, Y. Hort, and J. Shine (1986). Sequence and expression of human estrogen receptor complementary DNA. Science231:1150-1154. Google Scholar
S. Green, P. Walter, V. Kumar, A. Krust, P-M. Bornet, P. Argos, and P. Chambon (1986). Human oestrogen receptor cDNA: sequence, expression and homology to v-erb-A. Nature320:134-139. Google Scholar
M. Ponglikitmonkol, S. Green, and P. Chambon (1988). Genomas. mic organization of the human oestrogen receptor gene. EMBO J.7:3385-3388. Google Scholar
H. Fujii, C. Marsh, P. Cairns, D. Sidransky, and E. Gabrielson (1996). Genetic divergence in the clonal evolution of breast cancer. Cancer Res.56:1493-1497. Google Scholar
H. Iwase, J. M. Greenman, D. M. Barnes, L. Bobrow, S. Hodg-son, and C. G. Mathew (1995). Loss of heterozygosity of the oestrogen receptor gene in breast cancer. Brit. J. Cancer71:448-450. Google Scholar
C. K. Watts, M. L. Handel, R. J. B. King, and R. L. Sutherland (1992). Oestrogen receptor gene structure and function in breast cancer. J. Steroid Biochem. Mol. Biol.41:3-9. Google Scholar
S. M. Hill, S. A. W. Fuqua, G. C. Chamness, G. L. Greene, and W. L. McGuire (1989). Estrogen receptor expression in human breast cancer associated with an estrogen receptor gene restriction fragment length polymorphism. Cancer Res.49:145-148. Google Scholar
F. F. Parl, D. R. Cavener, and W. D. Dupont (1989). Genomic DNA analysis of the estrogen receptor gene in breast cancer. Breast Cancer Res. Treat.14:57-64. Google Scholar
L. Yaich, W. D. Dupont, D. R. Cavener, and F. F. Parl (1992). Analysis of the PvuII restriction fragment polymorphism and exon structure of the estrogen receptor gene in breast cancer and peripheral blood. Cancer Res.52:77-83. Google Scholar
N. Roodi, L. R. Bailey, W-Y. Kao, C. S. Verrier, C. J. Yee, W. D. Dupont, and F. F. Parl (1995). Estrogen receptor gene analysis in estrogen receptor-positive and receptor-negative primary breast cancer. J. Natl. Cancer Inst.87:446-451. Google Scholar
T. M. Garcia, T. M. Sanchez, J. L. Cox, P. A. Shaw, J. B. Ross, S. Lehre, and B. Schachter (1989). Identification of a variant form of the human estrogen receptor with an amino acid replacement. Nucleic Acid Res.17:8364. Google Scholar
Q.-X. Zhang, A. Borg, D. M. Wolf, S. Oesterreich, and S. A. W. Fuqua (1997). An estrogen receptor mutant wiath strong hormone-independ ent activity from a metastatic breast cancer. Cancer Res.57:1244-1249. Google Scholar
P. S. Karnik, S. Kulkarni, X-P. Liu, G. T. Budd, and R. M. Bukowski (1994). Estrogen receptor mutation in tamoxifen-resistant cancer. Cancer Res.54:349-353. Google Scholar
D. M. Wolf and V. C. Jordan (1994) The estrogen receptor from a tamoxifen stimulated MCF-7 tumor variant contains a point mutation in the ligand binding domain. Breast Cancer Res. Treat.31:129-138. Google Scholar
W. L. McGuire, G. C. Chamness, and S. A. W. Fuqua (1992). Estrogen receptor variants in clinical breast cancer. Mol. Endocrinol.5:1571-1577. Google Scholar
M. L. Graham, N. L. Kreet, L. A. Miller, K. K. Leslie, D. F. Gordon, W. M. Wood, L. L. Wei, and K. B. Horwitz (1990). T47Dco cells, genetically unstable and containing estrogen receptor mutations, are a model for the progression of breast cancer hormone resistance. Cancer Res.50:6208-6217. Google Scholar
J. J. Pink, S. Y. Jiang, M. Fritsch, and V. C. Jordan (1995). A unique MCF-7 human breast cancer cell line expressing an 80 kD estrogen receptor. Proc. Am. Assoc. Cancer Res.35:276. Google Scholar
Y. L. Ottaviano, J-P. Issa, F. F. Parl, H. S. Smith, S. B. Baylin, and N. E. Davidson (1994). Methylation of the estrogen recep-tor gene CpG island marks loss of estrogen receptor expression in human breast cancer cells. Cancer Res.54:2552-2555. Google Scholar
R. J. Weigel and E. C. deConinck (1993). Transcriptional con-trol of estrogen receptor in estrogen receptor negative breast carcinoma. Cancer Res.53:3472-3474. Google Scholar
C. Carmeci, E. C. deConinck, T. Lawton, D. A. Bloch, and R. J. Weigel (1997). Analysis of estrogen receptor messenger RNA in breast carcinomas from archival specimens is predictive of tumor biology. Am. J. Pathol.150:1563-1570. Google Scholar
E. C. deConinck, L. A. McPherson, and R. J. Weigel (1995). Transcriptional control of estrogen receptor in breast carcinomas. Mol. Cell. Biol.15:2191-2196. Google Scholar
L. A. McPherson, V. R. Baichwal, and R. J. Weigel (1997). Identification of ERF-1 as a member of the AP2 transcription factor family. Proc. Natl. Acad. Sci. USA94:4342-4347. Google Scholar
A. P. Bird (1986). CpG-rich islands and the function of DNA methylation. Nature321:209-213. Google Scholar
E. Li, C. Beard, and R. Jaenisch (1993). Role of DNA methyla-tion in genomic imprinting. Nature366:362-365. Google Scholar
T. Mohandas, R. S. Sparkes, and L. J. Shapiro (1981). Reactiva-tion of an inactive human X chromosome: evidence for X inactivation by DNA methylation. Science211:393-396. Google Scholar
H. Cedar (1988). DNA methylation and gene activity. Cell53:3. Google Scholar
P. W. Laird and R. Jainisch (1996). The role of DNA methyla-tion in cancer genetics and epigenetics. Ann. Rev. Genet.30:441-464. Google Scholar
J. G. Herman, F. Latif, Y. Weng, M. I. Lerman, B. Zbar, S. Liu, D. Samid, D. S. Duan, J. R. Gnarra, W. M. Linehan, and S. B. Baylin (1994). Silencing of the VHL-tumor suppressor gene by DNA methylation in renal carcinoma. Proc. Natl. Acad. Sci. USA91:9700-9704. Google Scholar
J. G. Herman, A. Merlo, L. Mao, R. G. Lapidus, J-P. Issa, N. E. Davidson, D. Sidransky, and S. B. Baylin (1995). Inactivation of the CDKN2/p16/M ST1 gene is frequently associated with aberrant DNA methylation in all common human cancers. Cancer Res.55:4525-4530. Google Scholar
J. G. Herman, J. Jen, A. Merlo, and S. B. Baylin (1996). Hypermethylati on-associated inactivation indicates a tumor suppressor role for p15INK4B1. Cancer Res.56:722-727. Google Scholar
W. H. Lee, R. A. Morton, J. I. Epstein, J. D. Brooks, P. A. Campbell, G. S. Bova, W. S. Hsieh, W. B. Isaacs, and W. G. Nelson (1994). Cytidine methylation of regulatory sequences near the pi-class glutathione S-transferase gene accompanies human prostatic carcinogenesis. Proc. Natl. Acad. Sci. USA91:11733-11737. Google Scholar
J. G. Graff, J. G. Herman, R. G. Lapidus, H. E. Chopra, R. Xu, D. F. Jarrard, W. B. Isaacs, P. M. Pitha, N. E. Davidson, and S. B. Baylin (1995). E-cadherin expression is silenced by DNA hypermethylatio n in human breast and prostate carcinoma. Cancer Res.55:5195-5199. Google Scholar
R. Piva, A. P. Rimondi, S. Hanau, I. Maestri, A. Alvisi, V. L. Kumar, and L. del Senno (1990). Different methylation of oestrogen receptor DNA in human breast carcinomas with and without oestrogen receptor. Brit. J. Cancer61:270-275. Google Scholar
N. S. Falette, S. A. W. Fuqua, G. C. Chamness, M. S. Cheah, G. L. Greene, and W. L. McGuire (1990). Estrogen receptor gene methylation in human breast tumors. Cancer Res.50:3974-3978. Google Scholar
A. T. Ferguson, R. G. Lapidus, S. B. Baylin, and N. E. Davidson (1995). Demethylation of the estrogen receptor gene in estrogen receptor-negative breast cancer cells can reactivate estrogen receptor gene expression. Cancer Res.55:2279-2283. Google Scholar
R. G. Lapidus, A. T. Ferguson, Y. L. Ottaviano, F. F. Parl, H. S. Smith, S. A. Weitzman, S. B. Baylin, J-P. J. Issa, and N. E. Davidson (1996). Methylation of estrogen and progesterone receptor genes 5′ CpG islands correlates with lack of ER and PR gene expression in breast tumors. Clinical Cancer Res.2:805-810. Google Scholar
M. F. Rousseau-Merck, M. Misrahi, E. Loosfelt, E. Milgrom, and R. von Beger (1987). Localization of the human progester-one receptor gene to chromosome 11q22q23. Human Genet.77:280-282. Google Scholar
I. P. Tomlinson, H. Nicolai, E. Solomon, and W. F. Bodmer (1996). The frequency and mechanism of loss of heterozygosity on chromosome 11q in breast cancer. J. Pathol.180:38-43. Google Scholar
R. Winqvist, G. M. Hampton, A. Mannermaa, G. Blanco, M. Alavaikko, H. Kiviniemi, P. J. Taskinen, G. A. Evans, F. A. Wright, I. Newsham, and W. K. Cavenee (1995). Loss of heterozygosity for chromosome 11 in primary human breast tumors is associated with poor survival after metastases. Cancer Res.55:2660-2664. Google Scholar
S. A. W. Fuqua, S. M. Hill, G. Chamness, M. G. Benedix, G. L. Greene, B. W. O' Malley, and W. L. McGuire (1991). Progesterone receptor gene restriction fragment length poly-morphism in human breast tumors. J. Natl. Cancer Inst.83:1157-1160. Google Scholar
T. P. Manolitsas, P. Englefield, D.M. Eccles, and I. G. Campbell (1997). No association of a 306-bp insertion polymorphism in the progesterone receptor gene with ovarian and breast cancer. Brit. J. Cancer75:1398-1399. Google Scholar
K. L. Satya-Prakash, S. Pathak, T. C. Hsu, M. Olive, and R. Cailleau (1981). Cytogenetic analysis on eight human breast tumor cell lines: high frequencies of 1q, 11q and HeLa-like marker chromosome. Cancer Genet. Cytogenet.3:61-73. Google Scholar
C. Mies and W. Voigt (1996). Sequence analysis of the DNA binding domain of the estrogen receptor gene in ER(+)/PR(-) breast cancer. Diagnostic Mol. Pathol.5:39-44. Google Scholar
L. Kastner, A. Krust, B. Turcotte, U. Stropp, L. Tora, H. Gro-nemeyer, and P. Chambon (1990). Two distinct estrogen-regulated promoters generate transcripts encoding the two functionally different human progesterone receptor forms A and B. EMBO J.9:1603-1614. Google Scholar
M. Misrahi, P. Venecie, P. Saugier-Veber, S. Sars, P. Dessen, and E. Milgrom (1993). Structure of the human progesterone receptor gene. Biochim. Biophys Acta1216:289-292. Google Scholar